Mouse Anti-Human KAI 1 Monoclonal Antibody, Unconjugated, Clone G-2 from Santa Cruz Biotechnology, Inc.
Rat Anti-Mouse TCR, Va 2 Monoclonal Antibody, Unconjugated, Clone B20.1 from CEDARLANE Laboratories Limited
Rat Anti-Mouse OSMR Monoclonal Antibody, Unconjugated, Clone 30-1 from MBL International
...gned for use with the ProQuest Two-Hybrid System (...letions in the endogenous GAL4 and GAL80 genes for...n also has leu2 and trp1 mutations for selection o...three GAL4 inducible reporter genes, providing fou...
Biology Products:...any researchers have believed women choose partner...ng, a new study from The University of Texas at Au...by their own attractiveness. , David Buss, psycho...he findings in Attractive Women Want it All: Good ... and Emotional Commitment in this months Evolution...
... neuron disease is a rare, devastating illness in ...les gradually deteriorate. One form of it, Lou Geh...), is familiar to the public in the lives of scien...om Mitch Alboms Tuesdays with Morrie was written. ...iguring out why these people develop the disease, ...
... Purdue University researchers have identified sev...the Midwest like southern Indiana and are resistan...ite with a recently confirmed presence in that par...esistance in soybeans to one nematode parasite doe...ther nematode species, said Andreas Westphal, assi...
Other Biology News:Do attractive women want it all? 2Motor neuron disease and toxic substances: Possible link? 2Motor neuron disease and toxic substances: Possible link? 3Soybean varieties viable in southern Indiana, resistant to root-knot nematode 2Soybean varieties viable in southern Indiana, resistant to root-knot nematode 3(Date:11/24/2009)... , The New York investmen... Ltd (ASX:NEU) has agreed an AU$6.7 mil convertibl... investor. The private placement was arranged by K...nd advisor. , New York (P...k investment bank KTA Capital, LLC ("KTA Capi...
(Date:11/24/2009)... , , ST. LOUIS, Nov. 24 /PRNewswire-Fi...AL ) will be presenting at the NASDAQ OMX conferen...on, 7:45 AM US/CST. Interested parties may listen ...le at http://inve s tor.sig m a a ldrich.c...ss this file. ,, About Sigma-Aldrich: Sig...
(Date:11/24/2009)... , , SAN MATEO, Calif., Nov. 24 /PRNe...X ), a biopharmaceutical company focused on develo...rapies, announced today that Anthony DiTonno, Pres... present at the 21st Annual Piper Jaffray Health C...he New York Palace Hotel in New York, New York. ,...
(Date:11/24/2009)... , , , Primary efficacy endpoint has ...ecurrent endometrial cancer, , QUEBEC CITY, N...nc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a ...ine therapy and oncology, today announced positive...ted cytotoxic peptide conjugate, AEZS-108 (formerl...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4